Celularity (CELU) Assets (2018 - 2026)
Celularity (CELU) posted Assets of $96.17 million for Q2 2026, down 20.0% from $120.28 million a year earlier and down 3.3% from the prior quarter.
Analysis
Celularity (CELU) Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Celularity's Assets came in at $107.33 million, down 19.1% from FY2024.
- Annual Assets has declined for five consecutive years, with a five-year compound annual growth rate of -24.3% (FY2020 to FY2025).
- In prior years, Celularity's Assets was $132.68 million in FY2024 (-7.8%), $143.89 million in FY2023 (-64.1%), $401.07 million in FY2022 (-3.2%) and $414.13 million in FY2021 (-3.9%).
- The Q2 2026 figure stands as the lowest quarterly Assets since Q4 2018.
- On a year-over-year basis, Assets has declined in each of the last 16 quarters, with an average decline of 15.1% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q2 2022, with growth of 234.3%; the weakest was Q4 2023, with a decline of 64.1%.
- According to Business Quant data, Assets for the three prior quarters was $99.48 million (Q1 2026), $107.33 million (Q4 2025) and $114.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.21 Bn | 1,108.80 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 632.33 Bn | 552.19 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 500.02 Bn | 473.13 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 355.31 Bn | 309.69 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 300.67 Bn | 264.66 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 263.56 Bn | 237.25 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.81 Bn | 193.20 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.42 Bn | 168.61 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Celularity | 29.79 Mn | 22.54 Mn | 3.09 Mn | 96.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.17 Mn |
| Mar 31, 2026 | 99.48 Mn |
| Dec 31, 2025 | 107.33 Mn |
| Sep 30, 2025 | 114.24 Mn |
| Jun 30, 2025 | 120.28 Mn |
| Mar 31, 2025 | 128.88 Mn |
| Dec 31, 2024 | 132.68 Mn |
| Sep 30, 2024 | 128.84 Mn |
| Jun 30, 2024 | 135.49 Mn |
| Mar 31, 2024 | 143.82 Mn |
| Dec 31, 2023 | 143.89 Mn |
| Sep 30, 2023 | 157.19 Mn |
| Jun 30, 2023 | 246.42 Mn |
| Mar 31, 2023 | 362.42 Mn |
| Dec 31, 2022 | 401.07 Mn |
| Sep 30, 2022 | 437.12 Mn |
| Jun 30, 2022 | 429.34 Mn |
| Mar 31, 2022 | 434.20 Mn |
| Dec 31, 2021 | 414.13 Mn |
| Sep 30, 2021 | 448.29 Mn |
API Access
Celularity Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CELU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();